Research

Chair, Partnership’s Research Advisory Group; Co-Chair, Canadian Cancer Research Alliance; Professor, Department of Oncology, Queen’s University; Director, Investigational New Drug Program, National Cancer Institute of Canada’s Clinical Trials Group.

Elizabeth Eisenhauer is based at Queen’s University in Kingston, Ontario, where she is a professor in the Department of Oncology. She is also director of the Investigational New Drug Program of the National Cancer Institute of Canada’s Clinical Trials Group.

Her major responsibilities lie in identifying and bringing into clinical trial novel cancer agents. Since 1982, Dr. Eisenhauer has been responsible for coordinating over 170 trials across Canada, the United States and Europe. In 2002, she was appointed to the board of directors of the National Cancer Institute of Canada and in 2006 became the institute’s President.

Dr. Eisenhauer holds a medical degree from Queen’s University and completed Royal College of Physicians and Surgeons training in both internal medicine and hematology. She has served on committees for many national and international bodies, including the Canadian Cancer Society, the Royal College of Physicians and Surgeons of Canada, the European Organisation for Research and Treatment of Cancer, the American Society of Clinical Oncology and the U.S. National Cancer Institute.